360 related articles for article (PubMed ID: 32233024)
1. Galacto-conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity.
González-Gualda E; Pàez-Ribes M; Lozano-Torres B; Macias D; Wilson JR; González-López C; Ou HL; Mirón-Barroso S; Zhang Z; Lérida-Viso A; Blandez JF; Bernardos A; Sancenón F; Rovira M; Fruk L; Martins CP; Serrano M; Doherty GJ; Martínez-Máñez R; Muñoz-Espín D
Aging Cell; 2020 Apr; 19(4):e13142. PubMed ID: 32233024
[TBL] [Abstract][Full Text] [Related]
2. Selective Elimination of Senescent Cancer Cells by Galacto-Modified PROTACs.
Chang M; Gao F; Gnawali G; Xu H; Dong Y; Meng X; Li W; Wang Z; Lopez B; Carew JS; Nawrocki ST; Lu J; Zhang QY; Wang W
J Med Chem; 2024 May; 67(9):7301-7311. PubMed ID: 38635879
[TBL] [Abstract][Full Text] [Related]
3. Galactose-modified duocarmycin prodrugs as senolytics.
Guerrero A; Guiho R; Herranz N; Uren A; Withers DJ; Martínez-Barbera JP; Tietze LF; Gil J
Aging Cell; 2020 Apr; 19(4):e13133. PubMed ID: 32175667
[TBL] [Abstract][Full Text] [Related]
4. Senolytic-Mediated Elimination of Head and Neck Tumor Cells Induced Into Senescence by Cisplatin.
Ahmadinejad F; Bos T; Hu B; Britt E; Koblinski J; Souers AJ; Leverson JD; Faber AC; Gewirtz DA; Harada H
Mol Pharmacol; 2022 Mar; 101(3):168-180. PubMed ID: 34907000
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors.
Zhu Y; Tchkonia T; Fuhrmann-Stroissnigg H; Dai HM; Ling YY; Stout MB; Pirtskhalava T; Giorgadze N; Johnson KO; Giles CB; Wren JD; Niedernhofer LJ; Robbins PD; Kirkland JL
Aging Cell; 2016 Jun; 15(3):428-35. PubMed ID: 26711051
[TBL] [Abstract][Full Text] [Related]
6. Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy.
Carpenter V; Saleh T; Min Lee S; Murray G; Reed J; Souers A; Faber AC; Harada H; Gewirtz DA
Biochem Pharmacol; 2021 Nov; 193():114765. PubMed ID: 34536356
[TBL] [Abstract][Full Text] [Related]
7. New agents that target senescent cells: the flavone, fisetin, and the BCL-X
Zhu Y; Doornebal EJ; Pirtskhalava T; Giorgadze N; Wentworth M; Fuhrmann-Stroissnigg H; Niedernhofer LJ; Robbins PD; Tchkonia T; Kirkland JL
Aging (Albany NY); 2017 Mar; 9(3):955-963. PubMed ID: 28273655
[TBL] [Abstract][Full Text] [Related]
8. Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity.
He Y; Zhang X; Chang J; Kim HN; Zhang P; Wang Y; Khan S; Liu X; Zhang X; Lv D; Song L; Li W; Thummuri D; Yuan Y; Wiegand JS; Ortiz YT; Budamagunta V; Elisseeff JH; Campisi J; Almeida M; Zheng G; Zhou D
Nat Commun; 2020 Apr; 11(1):1996. PubMed ID: 32332723
[TBL] [Abstract][Full Text] [Related]
9. A navitoclax-loaded nanodevice targeting matrix metalloproteinase-3 for the selective elimination of senescent cells.
Escriche-Navarro B; Garrido E; Sancenón F; García-Fernández A; Martínez-Máñez R
Acta Biomater; 2024 Mar; 176():405-416. PubMed ID: 38185231
[TBL] [Abstract][Full Text] [Related]
10. Combination of palbociclib with navitoclax based-therapies enhances in vivo antitumoral activity in triple-negative breast cancer.
Estepa-Fernández A; García-Fernández A; Lérida-Viso A; Blandez JF; Galiana I; Sancenon-Galarza F; Orzáez M; Martínez-Máñez R
Pharmacol Res; 2023 Jan; 187():106628. PubMed ID: 36566002
[TBL] [Abstract][Full Text] [Related]
11. One-Two Punch Therapy for the Treatment of T-Cell Malignancies Involving p53-Dependent Cellular Senescence.
Qing Y; Li H; Zhao Y; Hu P; Wang X; Yu X; Zhu M; Wang H; Wang Z; Guo Q; Hui H
Oxid Med Cell Longev; 2021; 2021():5529518. PubMed ID: 34603598
[TBL] [Abstract][Full Text] [Related]
12. Clearance of therapy-induced senescent tumor cells by the senolytic ABT-263 via interference with BCL-X
Saleh T; Carpenter VJ; Tyutyunyk-Massey L; Murray G; Leverson JD; Souers AJ; Alotaibi MR; Faber AC; Reed J; Harada H; Gewirtz DA
Mol Oncol; 2020 Oct; 14(10):2504-2519. PubMed ID: 32652830
[TBL] [Abstract][Full Text] [Related]
13. Effects and Related Mechanisms of the Senolytic Agent ABT-263 on the Survival of Irradiated A549 and Ca9-22 Cancer Cells.
Sato K; Iwasaki S; Yoshino H
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948029
[TBL] [Abstract][Full Text] [Related]
14. BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer.
Shahbandi A; Rao SG; Anderson AY; Frey WD; Olayiwola JO; Ungerleider NA; Jackson JG
Cell Death Differ; 2020 Nov; 27(11):3097-3116. PubMed ID: 32457483
[TBL] [Abstract][Full Text] [Related]
15. Senolytic Agent Navitoclax Inhibits Angiotensin II-Induced Heart Failure in Mice.
Jia K; Dai Y; Liu A; Li X; Wu L; Lu L; Bao Y; Jin Q
J Cardiovasc Pharmacol; 2020 Oct; 76(4):452-460. PubMed ID: 32675749
[TBL] [Abstract][Full Text] [Related]
16. EA.hy926 Cells and HUVECs Share Similar Senescence Phenotypes but Respond Differently to the Senolytic Drug ABT-263.
Abdelgawad IY; Agostinucci K; Ismail SG; Grant MKO; Zordoky BN
Cells; 2022 Jun; 11(13):. PubMed ID: 35805077
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological clearance of senescent cells improves survival and recovery in aged mice following acute myocardial infarction.
Walaszczyk A; Dookun E; Redgrave R; Tual-Chalot S; Victorelli S; Spyridopoulos I; Owens A; Arthur HM; Passos JF; Richardson GD
Aging Cell; 2019 Jun; 18(3):e12945. PubMed ID: 30920115
[TBL] [Abstract][Full Text] [Related]
18. Senolysis Enabled by Senescent Cell-Sensitive Bioorthogonal Tetrazine Ligation.
Chang M; Dong Y; Xu H; Cruickshank-Taylor AB; Kozora JS; Behpour B; Wang W
Angew Chem Int Ed Engl; 2024 Feb; 63(9):e202315425. PubMed ID: 38233359
[TBL] [Abstract][Full Text] [Related]
19. Discovery of PROTAC BCL-X
Zhang X; Thummuri D; Liu X; Hu W; Zhang P; Khan S; Yuan Y; Zhou D; Zheng G
Eur J Med Chem; 2020 Apr; 192():112186. PubMed ID: 32145645
[TBL] [Abstract][Full Text] [Related]
20. Identification of SYK inhibitor, R406 as a novel senolytic agent.
Cho HJ; Yang EJ; Park JT; Kim JR; Kim EC; Jung KJ; Park SC; Lee YS
Aging (Albany NY); 2020 May; 12(9):8221-8240. PubMed ID: 32379705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
